
DR LOUISE NEWSON: A wild chat about menopause
Wild with Sarah Wilson
Challenges with Pharmaceutical Companies and Hormone Replacement Therapy (HRT) for Menopause
The chapter delves into concerns about pharmaceutical companies' vested interests in hormone replacement therapy (HRT) for menopause, discussing issues of medication dependency, transparency, and profitability. It also explores the disparity between the demand for HRT and pharmaceutical companies' focus on newer, more lucrative drugs, as well as restrictions on HRT availability due to governmental regulations and market perceptions.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.